Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
Exclusive analysis of biotech, pharma, and the life sciences
In-depth analysis of biotech, pharma, and the life sciences
from some of the nation's most trusted and well-connected reporters in the industry
with STAT+ reporters and leading industry experts in our STAT+ Con
Many of us constantly look towards fat burners in order to assist with fat loss, appetite control, and intense energy. And we should, for that is what they are designed for. However, with a market so saturated, it can be difficult at times to really know which supplements out there are workin
Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
New York, USA – May 19, 2022 – BOC Sciences has been preparing for the world’s largest gathering of pharmaceutical industry for several months. This year, it attracts a great number of researchers who are interested in accelerating oligonucleotide, peptide, mRNA, and genome e
Maria Doa, Ph.D., Senior Director, Chemicals Policy; Lauren Ellis, MPH, Research Analyst; and Lariah Edwards, Ph.D., Post-Doctoral Fellow
The Environmental Defense Fund (EDF) recently filed comments on EPA’s Toxic Substances Control Act (TSCA) Collaborative Research Program to Supp
Article by Maddy Lauria May 20, 2022
Aditya Kunjapur, an assistant professor in the University of Delaware’s Department of Chemical and Biomolecular Engineering, is the recent recipient of prestigious early career
MELBOURNE, Australia--(BUSINESS WIRE )--Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that pharma grade raw materials were
We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience. You can read our Cookie Policy here.
Complete the form below and we will email you a PDF version of
R&D teams presenting posters, hosting symposium at Society for Investigative Dermatology annual meeting.
Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies. You can obtain detailed informat
